Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07718243 |
| Title | Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC (BLAZE) |
| Acronym | BLAZE |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Institute of Cancer Research, United Kingdom |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The Christie NHS Foundation Trust | Manchester | M20 4BX | United Kingdom | Details | ||
| The Royal Marsden NHS Foundation Trust - Drug Development Unit | Sutton | SM2 5PT | United Kingdom | Details |